Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many anticancer drugs target microtubules and induce apoptosis. However, improved microtubule-targeting drugs, such as STX140 and STX641, are being developed. These compounds induce cell cycle arrest and apoptosis in a variety of tumour cells. The mechanisms that induce apoptosis and the key mediators involved are elucidated in this study. Results demonstrate that STX140 and STX641 depolarise mitochondrial bioenergetics and activate caspase 3/7 in A2780, LNCaP and MCF-7 cancer cells. Furthermore, both compounds cause a significant reduction in the expression of survivin and XIAP. This work details the temporal organisation of apoptosis induced by two microtubule disruptors and highlights the role that the down-regulation of survivin and XIAP may play in this process.


Journal article


Anticancer Res

Publication Date





3751 - 3757


Adenosine Triphosphate, Apoptosis, Caspase 3, Caspase 7, Cell Cycle Proteins, Cell Growth Processes, Cell Line, Tumor, Down-Regulation, Enzyme Activation, Estrenes, Female, Humans, Inhibitor of Apoptosis Proteins, Male, Membrane Potential, Mitochondrial, Microtubule-Associated Proteins, Mitochondria, Ovarian Neoplasms, Prostatic Neoplasms, Tubulin Modulators